Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The report in March 1996 of 10 human cases of a novel from of Creutzfeldt-Jakob disease in the United Kingdom, and its possible link to the agent that causes bovine spongiform encephalopathy (BSE), raises many questions about the safety of animal-derived products and by-products entering the food chain or being used in medicine. This Memorandum updates the preventive measures put forward in 1991 to minimize the risks associated with the use of bovine-derived materials in medicinal products and medical devices.

Type

Conference paper

Publication Date

01/1997

Volume

75

Pages

505 - 513

Keywords

Milk, Animals, Cattle, Sheep, Humans, Zoonoses, Creutzfeldt-Jakob Syndrome, Encephalopathy, Bovine Spongiform, Blood Proteins, PrPC Proteins, Biocompatible Materials, Food Microbiology, Adult